249 related articles for article (PubMed ID: 22910460)
1. Effect of genetic variant in BICC1 on functional and structural brain changes in depression.
Bermingham R; Carballedo A; Lisiecka D; Fagan A; Morris D; Fahey C; Donohoe G; Meaney J; Gill M; Frodl T
Neuropsychopharmacology; 2012 Dec; 37(13):2855-62. PubMed ID: 22910460
[TBL] [Abstract][Full Text] [Related]
2. Effects of early life adversity and FKBP5 genotype on hippocampal subfields volume in major depression.
Mikolas P; Tozzi L; Doolin K; Farrell C; O'Keane V; Frodl T
J Affect Disord; 2019 Jun; 252():152-159. PubMed ID: 30986730
[TBL] [Abstract][Full Text] [Related]
3. GWAS-identified risk variants for major depressive disorder: Preliminary support for an association with late-life depressive symptoms and brain structural alterations.
Ryan J; Artero S; Carrière I; Maller JJ; Meslin C; Ritchie K; Ancelin ML
Eur Neuropsychopharmacol; 2016 Jan; 26(1):113-125. PubMed ID: 26391493
[TBL] [Abstract][Full Text] [Related]
4. Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.
Tozzi L; Carballedo A; Wetterling F; McCarthy H; O'Keane V; Gill M; Morris D; Fahey C; Meaney J; Frodl T
Neuropsychopharmacology; 2016 Jan; 41(2):487-97. PubMed ID: 26076833
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones.
Davidson S; Shanley L; Cowie P; Lear M; McGuffin P; Quinn JP; Barrett P; MacKenzie A
Pharmacogenomics J; 2016 Aug; 16(4):366-74. PubMed ID: 26440730
[TBL] [Abstract][Full Text] [Related]
6. BICC1 expression is elevated in depressed subjects and contributes to depressive behavior in rodents.
Ota KT; Andres W; Lewis DA; Stockmeier CA; Duman RS
Neuropsychopharmacology; 2015 Feb; 40(3):711-8. PubMed ID: 25178406
[TBL] [Abstract][Full Text] [Related]
7. Early life adversity is associated with a smaller hippocampus in male but not female depressed in-patients: a case-control study.
Colle R; Segawa T; Chupin M; Tran Dong MN; Hardy P; Falissard B; Colliot O; Ducreux D; Corruble E
BMC Psychiatry; 2017 Feb; 17(1):71. PubMed ID: 28202012
[TBL] [Abstract][Full Text] [Related]
8. Underlying mechanisms of recombinant adeno-associated virus-mediated bicaudal C homolog 1 overexpression in the medial prefrontal cortex of mice with induced depressive-like behaviors.
Wang Z; Zhou D; Li S; Zhang Y; Wang C
Brain Res Bull; 2019 Aug; 150():35-41. PubMed ID: 31102751
[TBL] [Abstract][Full Text] [Related]
9. Structural MRI correlates for vulnerability and resilience to major depressive disorder.
Amico F; Meisenzahl E; Koutsouleris N; Reiser M; Möller HJ; Frodl T
J Psychiatry Neurosci; 2011 Jan; 36(1):15-22. PubMed ID: 20964952
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder.
Cui L; Gong X; Tang Y; Kong L; Chang M; Geng H; Xu K; Wang F
Neural Plast; 2016; 2016():9162590. PubMed ID: 27843651
[TBL] [Abstract][Full Text] [Related]
11. Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.
Han KM; Won E; Sim Y; Kang J; Han C; Kim YK; Kim SH; Joe SH; Lee MS; Tae WS; Ham BJ
Sci Rep; 2017 Feb; 7():42621. PubMed ID: 28198448
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in CACNA1C affects neural processing in major depression.
Backes H; Dietsche B; Nagels A; Konrad C; Witt SH; Rietschel M; Kircher T; Krug A
J Psychiatr Res; 2014 Jun; 53():38-46. PubMed ID: 24612926
[TBL] [Abstract][Full Text] [Related]
13. Vesicular monoamine transporter 1 gene polymorphism and white matter integrity in major depressive disorder.
Won E; Han KM; Kang J; Kim A; Yoon HK; Chang HS; Park JY; Lee MS; Greenberg T; Tae WS; Ham BJ
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():138-145. PubMed ID: 28408293
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.
Tozzi L; Farrell C; Booij L; Doolin K; Nemoda Z; Szyf M; Pomares FB; Chiarella J; O'Keane V; Frodl T
Neuropsychopharmacology; 2018 Apr; 43(5):1138-1145. PubMed ID: 29182159
[TBL] [Abstract][Full Text] [Related]
15. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
[TBL] [Abstract][Full Text] [Related]
16. TESC gene-regulating genetic variant (rs7294919) affects hippocampal subfield volumes and parahippocampal cingulum white matter integrity in major depressive disorder.
Han KM; Won E; Kang J; Choi S; Kim A; Lee MS; Tae WS; Ham BJ
J Psychiatr Res; 2017 Oct; 93():20-29. PubMed ID: 28575645
[TBL] [Abstract][Full Text] [Related]
17. The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population.
Liu W; Yan H; Zhou D; Cai X; Zhang Y; Li S; Li H; Li S; Zhou DS; Li X; Zhang C; Sun Y; Dai JP; Zhong J; Yao YG; Luo XJ; Fang Y; Zhang D; Ma Y; Yue W; Li M; Xiao X
Transl Psychiatry; 2019 Dec; 9(1):333. PubMed ID: 31819045
[TBL] [Abstract][Full Text] [Related]
18. Impact of family history and depression on amygdala volume.
Saleh K; Carballedo A; Lisiecka D; Fagan AJ; Connolly G; Boyle G; Frodl T
Psychiatry Res; 2012 Jul; 203(1):24-30. PubMed ID: 22867951
[TBL] [Abstract][Full Text] [Related]
19. Association of a SIRT1 polymorphism with changes of gray matter volume in patients with first-episode medication-naïve major depression.
Nan D; Yuqi C; Zonglin S; Chenglong D; Na L; Fang L; Cong Z; Xiufeng X
Psychiatry Res Neuroimaging; 2020 Jul; 301():111101. PubMed ID: 32447184
[TBL] [Abstract][Full Text] [Related]
20. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.
Carballedo A; Amico F; Ugwu I; Fagan AJ; Fahey C; Morris D; Meaney JF; Leemans A; Frodl T
Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):537-48. PubMed ID: 22585743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
